Compare Braze Inc (BRZE) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Braze Inc vs Centene Corp — how do they compare? Braze Inc trades at $28.27 (market cap $3.24B), while Centene Corp trades at $65.58 (market cap $32.89B). The key difference: Centene Corp is far larger — about 10.2× Braze Inc's market cap, and Centene Corp is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.
| BRZE | CNC | |
|---|---|---|
Market Cap | $3.24B | $32.89B |
Sector | Technology | Health |
52-Week High | $36.19 | $68.72 |
52-Week Low | $15.79 | $26.17 |
Enterprise Value | $2.93B | $21.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Braze (BRZE) trades at $26.54, up 3.23% with bullish technical signals from moving averages. The company shows strong revenue growth trajectory from $238M in 2022 to $593M in 2025, though profitability remains elusive with a -15.51% net margin. Recent Q1 2027 earnings met expectations at $0.10 per share, while analyst sentiment remains overwhelmingly positive with 24 buy ratings and a $34.78 consensus target representing 31% upside potential.
The investment case hinges on Braze's accelerating revenue growth and market leadership in customer engagement software, offset by persistent losses and insider selling. While technical indicators support near-term momentum, execution on profitability remains the key catalyst for sustained upside. Risks include competitive pressures and the company's ability to convert growth into sustainable earnings.
Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.
Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Braze Inc
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
